3 Biotech Stocks That Are too Cheap to Ignore
Our Motley Fool roundtable likes Intercept Pharma, Viking Therapeutics, and Vir Bio.
Source: fool.com
Stay updated with breaking news from Intercept Pharma. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Our Motley Fool roundtable likes Intercept Pharma, Viking Therapeutics, and Vir Bio.
The holds were lifted by the FDA in July of 2020, but the company’s timeline had been severely set back by the miscalculation.